Wason J
Latest
- Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?
- Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential
- Revisiting the JOQUER trial: Stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine
- Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: A structured summary of a study protocol for a randomised controlled trial
- Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods
- Statistical consideration when adding new arms to ongoing clinical trials: The potentials and the caveats
- Mentalization for Offending Adult Males (MOAM): Study protocol for a randomized controlled trial to evaluate mentalization-based treatment for antisocial personality disorder in male offenders on community probation
- PSU4 Value of information for adaptive trials: Proof of concept study in multi-arm multi-stage trials of interventions for the prevention of surgical site infections
- Ensuring that COVID-19 research is inclusive: Guidance from the NIHR INCLUDE project
- Efficient adaptive designs for clinical trials of interventions for COVID-19
- Including non-concurrent control patients in the analysis of platform trials: Is it worth it?
- The Adaptive designs CONSORT Extension (ACE) statement: A checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
- Analysis of responder-based endpoints: improving power through utilising continuous components
- Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): 5-year follow-up of a pragmatic, randomised, controlled, superiority trial
- Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): Study protocol for a randomised controlled trial
- Prevalence of multiplicity and appropriate adjustments among cardiovascular randomized clinical trials published in major medical journals
- Developing a composite outcome measure for frailty prevention trials - Rationale, derivation and sample size comparison with other candidate measures
- Imaging breast cancer using hyperpolarized carbon-13 MRI
- Overestimated treatment effects in randomised phase II trials: What's up doctor?
- To add or not to add a new treatment arm to a multiarm study: A decision-theoretic framework
- The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: Findings from the EpAID study
- Evaluation of PR3-ANCA status after rituximab for ANCA-associated vasculitis
- Effect of sleep deprivation and exercise on reaction threshold in peanut-allergic adults: A randomised controlled study
- Anti-VEGF intervention in neovascular AMD: Benefits and risks restated as natural frequencies
- Design of Multi-Arm, Multi-Stage Trials in Oncology
- Design of experiments for a confirmatory trial of precision medicine
- Biomarker-guided trials: Challenges in practice
- Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
- A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol
- Healthy Campus Trial: A multiphase optimization strategy (MOST) fully factorial trial to optimize the smartphone cognitive behavioral therapy (CBT) app for mental health promotion among university students: Study protocol for a randomized controlled trial
- Response‐adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
- Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): A pragmatic, randomised controlled, superiority trial
- Training nurses in a competency framework to support adults with epilepsy and intellectual disability: The EpAID cluster RCT
- The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI
- Imaging biomarker roadmap for cancer studies
- An adaptive design for updating the threshold value of a continuous biomarker
- Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: Study protocol for a cluster randomised controlled trial
- Endoplasmic reticulum stress, the unfolded protein response and development of colon adenocarcinoma
- HLA associations in South Asian multiple sclerosis
- Evaluation of multisystemic therapy pilot services in Services for Teens Engaging in Problem Sexual Behaviour (STEPS-B): Study protocol for a randomized controlled trial
- Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design
- Multi-Arm Multi-Stage Designs for Clinical Trials with Treatment Selection
- Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax
- Response‐adaptive randomization for multi‐arm clinical trials using the forward looking Gittins index rule
- Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges
- Confounding in association studies: Month of birth and multiple sclerosis
- A multi-stage drop-the-losers design for multi-arm clinical trials
- Comment on: Month of birth and risk of multiple sclerosis: Confounding and adjustments
- Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.
- Evaluation of multisystemic therapy pilot services in the Systemic Therapy for At Risk Teens (START) trial: Study protocol for a randomised controlled trial
- Confounding underlies the apparent month of birth effect in multiple sclerosis
- The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma
- Some recommendations for multi-arm multi-stage trials
- Identifying combined design and analysis procedures in two-stage trials with a binary end point
- Risk in complex genetics: "All models are wrong but some are useful"
- Accelerated BEP: A phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis
- What role for genetics in the prediction of multiple sclerosis?
- Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor